Population Health Research Institute, St George's, University of London, Cranmer Terrace, London, SW17 0RE, England, UK.
School of Psychology & Clinical Language Sciences, University of Reading, Earley Gate, Reading, RG6 6AL, England, UK.
BMC Psychiatry. 2020 Mar 17;20(1):129. doi: 10.1186/s12888-020-02528-w.
Psychosis often causes significant distress and impacts not only in the individuals, but also those close to them. Many relatives and friends ('carers') provide long-term support and need resources to assist them. We have co-produced a digital mental health intervention called COPe-support (Carers fOr People with Psychosis e-support) to provide carers with flexible access to high quality psychoeducation and interactive support from experts and peers. This study evaluates the effectiveness of COPe-support to promote mental wellbeing and caregiving experiences in carers.
This study is a single-blind, parallel arm, individually randomized controlled trial (RCT) comparing COPe-support, with attention control. Both groups continue to receive usual care. COPe-support provides interactive web-based psychoeducation on psychosis-related issues, wellbeing-promotion and network support through forums. The attention-control is a non-interactive online information resource pack. Carers living in England are eligible if they provide at least weekly support to a family member or close friend affected by psychosis, and use internet communication (including emails) daily. All trial procedures are run online, including collection of outcome measurements which participants will directly input into our secure platform. Following baseline assessment, a web-based randomization system will be used to allocate 360 carers to either arm. Participants have unlimited access to the allocated condition for 40 weeks. Data collection is at three time points (10, 20, and 40 weeks after randomization). Analyses will be conducted by trial statisticians blinded to allocation. The primary outcome is mental wellbeing measured by Warwick Edinburgh Mental Wellbeing Scale (WEMWBS), at 20 weeks. As well as an intention-to-treat analysis, a complier average causal effect (CACE) analysis will be conducted to estimate the intervention effect in participants who have accessed COPe-support content twice or more. The secondary objectives and analysis will examine other health and caregiving-related outcomes and explore mechanisms. In a process evaluation, we will interview 20% of the intervention arm participants regarding the acceptability of COPe-support. We will explore in detail participants' usage patterns.
The results of this trial will provide valuable information about the effectiveness of COPe-support in promoting wellbeing and caregiving experiences in carers.
The RCT is registered with the Current Controlled Trials registration (ISRCTN 89563420, registration date: 02/03/2018).
精神病往往会给患者及其亲属带来严重的困扰。许多亲属和朋友(“照顾者”)为患者提供长期支持,并需要资源来帮助他们。我们共同开发了一种名为 COPe-support 的数字心理健康干预措施,为照顾者提供灵活获取高质量精神健康教育和专家及同行互动支持的途径。本研究评估了 COPe-support 对改善照顾者的心理健康和照顾体验的有效性。
本研究为一项单盲、平行臂、个体随机对照试验(RCT),比较 COPe-support 与注意力对照。两组均继续接受常规护理。COPe-support 通过论坛提供与精神病相关问题、幸福感促进和网络支持相关的互动式网络精神健康教育。注意力对照是一种非互动式在线信息资源包。居住在英格兰的照顾者如果每周至少为受精神病影响的家庭成员或亲密朋友提供一次支持,并且每天使用互联网通信(包括电子邮件),则有资格参加试验。所有试验程序均在线运行,包括参与者直接输入我们安全平台的结果测量。基线评估后,将使用基于网络的随机系统将 360 名照顾者随机分配到任一组。参与者可在 40 周内无限次访问分配的条件。数据收集在随机分组后 10、20 和 40 周进行。分析将由试验统计学家对分配情况进行盲法处理。主要结局指标是 20 周时用华威-爱丁堡幸福感量表(WEMWBS)测量的心理健康。除意向治疗分析外,还将进行遵从平均因果效应(CACE)分析,以估计接受 COPe-support 内容两次或更多次的参与者的干预效果。次要目标和分析将检查其他健康和护理相关结果,并探索机制。在过程评估中,我们将对干预组的 20%参与者进行 COPe-support 可接受性访谈。我们将详细探讨参与者的使用模式。
该试验的结果将提供有关 COPe-support 对改善照顾者幸福感和照顾体验的有效性的宝贵信息。
该 RCT 已在当前对照试验注册(ISRCTN 89563420,注册日期:2018 年 3 月 2 日)。